• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

antibodies

Saplings growing with increasing denominations of money wrapped around them
Biotech

Regeneron backs $75M series A for antibody upstart Infinimmune

The raise will support two eczema drugs that Infinimmune plans to push into the clinic next year.
Darren Incorvaia Aug 11, 2026 8:00am
3d blood test rack in front of a blood drop with a magnifying glass

Merck enlists antibody hunter Infinimmune for $838M biobucks

Mar 31, 2026 8:00am
Red throne

J&J, Royalty to co-fund $500M autoimmune antibody program

Mar 30, 2026 10:07am
Living cells illustration Cells membrane with nucleus are floating Medical and science concept background 3D render

After $1B fundraise, Xaira breaks silence on AI work

Mar 17, 2026 2:52pm
Connection together puzzle pieces Concept of business strategy collaboration

Agilent makes $950M move to acquire Biocare

Mar 11, 2026 3:00pm
a lot of scissors

BioAtla lays off 70% of workforce, seeks buyers for antibodies

Mar 2, 2026 9:40am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings